×
Back to Agenda
Transforming Women’s Health Science: Closing the Innovation Gap and Accelerating Impact
Session Chair(s)
Martin Hodosi, MS
Partner, Healthcare and Life Sciences Practices, Kearney, United States
This session presents insights from the Women’s Health Innovation Radar, highlighting global evidence gaps and emerging research priorities. It explores strategic and policy implications to accelerate scientific and clinical progress in women’s health.
Learning Objective : Identify key global evidence gaps and emerging areas of activity in women’s health R&D; Recognize how patterns in scientific evidence and clinical research can guide strategic and policy priorities in women’s health; Outline actionable levers, scientific, clinical, and policy-related, that can accelerate progress in women’s health innovation.
Speaker(s)
Victoria DiBiaso, BSN, MPH, RN
Head of Patient Informed Development & Health Value Translation, Sanofi, France
-
Katherine Senter, MPH
Assistant Director, Cancer Clinical Research Operations, Sidney Kimmel Cancer Center – Jefferson Health, United States
-
Sanj Singh, MBA
CEO, Temple Therapeutics, Netherlands
-
Representative Invited
Director, Division of Pediatric and Maternal Health, Office of New Drugs, CDER, FDA, United States
Panelist
Have an account?